Gene · 5891
Papers1,940
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,940
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Roles of autophagy-related genes in the therapeutic effects of Xuanfei Pingchuan capsules on chronic obstructive pulmonary disease based on transcriptome sequencing analysis. | Front Pharmacol | 2023 | 37274101 | PubTator, text mining | PubMed |
| The blood proteome of imminent lung cancer diagnosis. | Nat Commun | 2023 | 37264016 | PubTator, text mining | PubMed |
| Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism. | Front Endocrinol (Lausanne) | 2023 | 37260441 | PubTator, text mining | PubMed |
| Integration of molecular docking, molecular dynamics and network pharmacology to explore the multi-target pharmacology of fenugreek against diabetes. | J Cell Mol Med | 2023 | 37257051 | PubTator, text mining | PubMed |
| Therapeutic potential of urine exosomes derived from rats with diabetic kidney disease. | Front Endocrinol (Lausanne) | 2023 | 37251672 | PubTator, text mining | PubMed |
| Neutrophil extracellular trap is an important connection between hemodialysis and acute myocardial infarction. | Ren Fail | 2023 | 37246754 | PubTator, text mining | PubMed |
| Development of Procathepsin L (pCTS-L)-Inhibiting Lanosterol-Carrying Liposome Nanoparticles to Treat Lethal Sepsis. | Int J Mol Sci | 2023 | 37239992 | PubTator, text mining | PubMed |
| Ependyma in Neurodegenerative Diseases, Radiation-Induced Brain Injury and as a Therapeutic Target for Neurotrophic Factors. | Biomolecules | 2023 | 37238624 | PubTator, text mining | PubMed |
| Exploring the mechanism of Ginkgo biloba L. leaves in the treatment of vascular dementia based on network pharmacology, molecular docking, and molecular dynamics simulation. | Medicine (Baltimore) | 2023 | 37233418 | PubTator, text mining | PubMed |
| Insights into Advanced Neurological Dysfunction Mechanisms Following DBS Surgery in Parkinson's Patients: Neuroinflammation and Pyroptosis. | Curr Issues Mol Biol | 2023 | 37232753 | PubTator, text mining | PubMed |
| Identification of Probucol as a candidate for combination therapy with Metformin for Type 2 diabetes. | NPJ Syst Biol Appl | 2023 | 37221264 | PubTator, text mining | PubMed |
| The role of miRNA in colorectal cancer diagnosis: A pilot study. | Oncol Lett | 2023 | 37216163 | PubTator, text mining | PubMed |
| Aging, cell senescence, the pathogenesis and targeted therapies of intervertebral disc degeneration. | Front Pharmacol | 2023 | 37214476 | PubTator, text mining | PubMed |
| Quantitative proteomic studies addressing unmet clinical needs in sarcoma. | Front Oncol | 2023 | 37197427 | PubTator, text mining | PubMed |
| Using Advanced Bioinformatics Tools to Identify Novel Therapeutic Candidates for Proliferative Vitreoretinopathy. | Transl Vis Sci Technol | 2023 | 37191619 | PubTator, text mining | PubMed |
| Oscillating Glucose Induces the Increase in Inflammatory Stress through Ninjurin-1 Up-Regulation and Stimulation of Transport Proteins in Human Endothelial Cells. | Biomolecules | 2023 | 37189375 | PubTator, text mining | PubMed |
| Exploring the therapeutic mechanisms of Gleditsiae Spina acting on pancreatic cancer via network pharmacology, molecular docking and molecular dynamics simulation. | RSC Adv | 2023 | 37181515 | PubTator, text mining | PubMed |
| Pilot Study: The Effectiveness of Hyperbaric Oxygen Therapy in the Treatment of Periodontitis in Patients with Type 2 Diabetes. | Healthcare (Basel) | 2023 | 37174886 | PubTator, text mining | PubMed |
| Redefining Autoimmune Disorders' Pathoetiology: Implications for Mood and Psychotic Disorders' Association with Neurodegenerative and Classical Autoimmune Disorders. | Cells | 2023 | 37174637 | PubTator, text mining | PubMed |
| Mechanism of Danggui Sini underlying the treatment of peripheral nerve injury based on network pharmacology and molecular docking: A review. | Medicine (Baltimore) | 2023 | 37171334 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5891/papers?page=20